Cargando…

Clinical Effectiveness of Erlova in EGFR-Mutated Non-Small Cell Lung Cancer: An Affordable Price with Clinical Benefit

BACKGROUND: Thyrosin kinase inhibitors (TKIs) is approved for the first line treatment of non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutation. This study performed to assess clinical effectiveness and safety of Erlova (generic form of Erlotinib). METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seifi, Sharareh, Salimi, Babak, Esfahani-Monfared, Zahra, Radmanesh, Ramin, Yaghoubifard, Saeed, Talebianpour, Sara, Khosravi, Adnan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375593/ https://www.ncbi.nlm.nih.gov/pubmed/35485670 http://dx.doi.org/10.31557/APJCP.2022.23.4.1155

Ejemplares similares

A Phase IV Efficacy Study of Formeta Plus Carboplatin as First-Line Treatment of Advanced Non-Squamous, Non-Small Cell Lung Cancer in Iran: An Affordable Price with Clinical Benefit
por: Khosravi, Adnan, et al.
Publicado: (2018)

Thymoma Recurrence and its Predisposing Factors in Iranian Population: a Single Center Study
por: Seifi, Sharareh, et al.
Publicado: (2019)

Alvopem(®) (pemetrexed) safety assessment in patients with non-small cell lung cancer or malignant pleural mesothelioma: a post-marketing surveillance
por: Seifi, Sharareh, et al.
Publicado: (2023)

Prospective Randomized Phase II Parallel Study of Vinorelbine Maintenance Therapy versus Best Supportive Care in Advanced Non-Small Cell Lung Cancer
por: Khosravi, Adnan, et al.
Publicado: (2017)

Bilateral Lymphoblastic Lymphoma of Breast Mimicking Inflammatory Breast Cancer: A Case Report and Review of Literature
por: Seifi, Sharareh, et al.
Publicado: (2015)

Circulating free DNA concentration as a marker of disease recurrence and metastatic potential in lung cancer
por: Mirtavoos-Mahyari, Hanifeh, et al.
Publicado: (2019)

T790M and Acquired Resistance of Epidermal Growth Factor Receptor to Tyrosine Kinase Inhibitors in Patients with Lung Adenocarcinoma
por: Mirtavoos-Mahyari, Hanifeh, et al.
Publicado: (2022)

Cell Free Tumoral DNA Versus Paraffin Block Epidermal Growth Factor Receptor Mutation Detection in Patients with Non-Small Cell Lung Cancer
por: Mirtavoos-Mahyari, Hanifeh, et al.
Publicado: (2019)

Comparing Docetaxel Plus Cisplatin with Paclitaxel Plus Carboplatin in Chemotherapy-Naïve Patients with Advanced Non-Small-Cell Lung Cancer: a Single Institute Study
por: Khodadad, Kian, et al.
Publicado: (2014)

The Frequency of Epidermal Growth Factor Receptor (EGFR) Mutation in Patients with Lung Adenocarcinoma Referred to a Lung Diseases Hospital; A Cross-Sectional Study from Iran
por: Mohammadi, Sotoudeh, et al.
Publicado: (2022)

Human Epidermal Growth Factor Receptor 2 and Estrogen Receptor Status in Respect to Tumor Characteristics in Non-Metastatic Breast Cancer
por: Mirtavoos-Mahyari, Hanifeh, et al.
Publicado: (2014)

Price, availability and affordability of medicines
por: Mhlanga, Brenda S., et al.
Publicado: (2014)

Overexpression of HER2/neu as a Prognostic Value in Iranian Women With Early Stage Breast Cancer; A Single Institute Study
por: Mirtavoos Mahyari, Hanifeh, et al.
Publicado: (2014)

Two thymus-related autoimmune disorders: a case report and review of the literature
por: Mirtavoos-Mahyari, Hanifeh, et al.
Publicado: (2014)

Open access: What price affordability?
por: Poynder, Richard
Publicado: (2014)

An international analysis of the price and affordability of beer
por: Blecher, Evan, et al.
Publicado: (2018)

Prices, availability and affordability of medicines in Rwanda
por: Bizimana, Thomas, et al.
Publicado: (2020)

Affordability and Price Increases of New Cancer Drugs in Clinical Guidelines, 2007–2016
por: Hwang, Thomas J, et al.
Publicado: (2018)

Analysis of Cisplatin-Induced Ototoxicity Risk Factors in Iranian Patients with Solid Tumors: a Cohort, Prospective and Single Institute Study
por: Monfared, Zahra Esfahani, et al.
Publicado: (2017)

Serum Interleukin-27 Level in Different Clinical Stages of Lung Cancer
por: Babadi, Akbar Soleimani, et al.
Publicado: (2019)

Medicine prices, availability and affordability in Sri Lanka
por: Senarathna, S.M.D.K. Ganga, et al.
Publicado: (2011)

Availability, prices and affordability of essential medicines in Haiti
por: Chahal, Harinder Singh, et al.
Publicado: (2013)

Evaluating Drug Prices, Availability, Affordability, and Price Components: Implications for Access to Drugs in Malaysia
por: Babar, Zaheer Ud Din, et al.
Publicado: (2007)

Factors Impacting Pharmaceutical Prices and Affordability: Narrative Review
por: Lee, Kah Seng, et al.
Publicado: (2020)

WHO key access antibiotics price, availability and affordability in private sector pharmacies in Pakistan
por: Saleem, Zikria, et al.
Publicado: (2021)

Affordability of essential medicine prices in Malaysia’s private health sector
por: Ahmad, Nur Sufiza, et al.
Publicado: (2018)

The availability, price and affordability of essential antibacterials in Hubei province, China
por: Wu, Guangjie, et al.
Publicado: (2018)

Availability, prices and affordability of essential medicines in Zhejiang Province, China
por: Dong, Zuojun, et al.
Publicado: (2020)

Retail pharmacy prescription medicines’ availability, prices and affordability in Eswatini
por: Shambira, Garikai, et al.
Publicado: (2021)

Availability, Price and Affordability of Psychotropic Medicines in Addis Ababa, Ethiopia
por: Habte, Fikreselam, et al.
Publicado: (2023)

Availability, price, and affordability of antiseizure medicines in Addis Ababa, Ethiopia
por: Hailemariam, Fikreselam Habte, et al.
Publicado: (2023)

Affordable Prices Without Threatening the Oncological R&D Pipeline—An Economic Experiment on Transparency in Price Negotiations
por: Franzen, Nora, et al.
Publicado: (2022)

Prices and Clinical Benefit of National Price-Negotiated Anticancer Medicines in China
por: Zhang, Yichen, et al.
Publicado: (2022)

Access to Insulin Products in Pakistan: A National Scale Cross-Sectional Survey on Prices, Availability, and Affordability
por: Saeed, Amna, et al.
Publicado: (2022)

SKI CLUB - THE SKI SEASON IS APPROACHING! GET IN SHAPE - AT AN AFFORDABLE PRICE!
por: staff Association
Publicado: (2022)

Can Price Transparency Contribute to More Affordable Patient Access to Medicines?
por: Vogler, Sabine, et al.
Publicado: (2017)

Healthy diets ASAP – Australian Standardised Affordability and Pricing methods protocol
por: Lee, Amanda J, et al.
Publicado: (2018)

Antiepileptic Drug Prices, Availability and Affordability in a Resource-Limited Setting
por: Singh, Karan, et al.
Publicado: (2020)

Evaluation of Availability, Prices, and Affordability of Selected Essential Medicines in Balochistan, Pakistan
por: Bibi, Murad, et al.
Publicado: (2022)

Price, Availability and Affordability of Anti-Cancer Medicines in Addis Ababa, Ethiopia
por: Alemu, Bemnet Atlaw, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hfjvqtums0hk93jcmika3avrd0